Suppr超能文献

肝细胞癌的抗原标志物。

Antigenic markers of hepatocellular carcinoma.

作者信息

Chedid A, Chejfec G, Eichorst M, Villamil F, Terg R, Telenta M, Hojman R

机构信息

Department of Pathology, University of Health Sciences, Chicago Medical School, IL 60064.

出版信息

Cancer. 1990 Jan 1;65(1):84-7. doi: 10.1002/1097-0142(19900101)65:1<84::aid-cncr2820650118>3.0.co;2-d.

Abstract

One hundred thirty-five hepatocellular carcinomas were examined for the presence of antigenic tumor markers by the avidin-biotin-peroxidase complex method. Ninety-seven were from the US and 38 came from Argentina. The following markers were tested: alpha-fetoprotein (AFP), alpha-1-antitrypsin (AAT), hepatitis B surface antigen (HBsAg), hepatitis B core antigen (HBcAg), hepatitis D delta antigen (HD delta Ag), and Mallory's bodies (MB). In the US cases, AFP was present in 43%, AAT in 41%, HBsAg in 17%, and MB in 48%. Both HBcAg and HD delta Ag were absent. In the cases from Argentina, AFP was found in 26% and AAT in 18%. None of the other antigens were seen. Thirteen US tumors expressed three antigens and two four antigens simultaneously. This study reveals in humans a heterogenous expression of antigens by neoplastic hepatocytes with geographic differences, possibly due to multiple factors such as alcohol consumption or prevalence of hepatitis B infection.

摘要

采用抗生物素蛋白-生物素-过氧化物酶复合物法对135例肝细胞癌进行了抗原性肿瘤标志物检测。其中97例来自美国,38例来自阿根廷。检测了以下标志物:甲胎蛋白(AFP)、α1抗胰蛋白酶(AAT)、乙型肝炎表面抗原(HBsAg)、乙型肝炎核心抗原(HBcAg)、丁型肝炎δ抗原(HDδAg)和马洛里小体(MB)。在美国病例中,AFP阳性率为43%,AAT为41%,HBsAg为17%,MB为48%。HBcAg和HDδAg均未检出。在阿根廷病例中,AFP阳性率为26%,AAT为18%。未发现其他抗原。13例美国肿瘤同时表达三种抗原,2例同时表达四种抗原。本研究揭示了人类肿瘤性肝细胞抗原表达的异质性及地域差异,可能是由饮酒或乙型肝炎感染率等多种因素所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验